I. Abaitua

590 total citations
21 papers, 380 citations indexed

About

I. Abaitua is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, I. Abaitua has authored 21 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Rheumatology and 6 papers in Genetics. Recurrent topics in I. Abaitua's work include Eosinophilic Disorders and Syndromes (6 papers), Genomics and Rare Diseases (5 papers) and Mast cells and histamine (4 papers). I. Abaitua is often cited by papers focused on Eosinophilic Disorders and Syndromes (6 papers), Genomics and Rare Diseases (5 papers) and Mast cells and histamine (4 papers). I. Abaitua collaborates with scholars based in Spain, United States and Italy. I. Abaitua's co-authors include Manuel Posada de la Paz, Edwin M. Kilbourne, Agustı́n Gómez de la Cámara, Rossanne M. Philen, Carlos Lahoz, Verónica Alonso‐Ferreira, Benedetto Terracini, Robert H. Hill, Benoît Nemery and S. Tarkowski and has published in prestigious journals such as Environmental Health Perspectives, Food and Chemical Toxicology and Epidemiology.

In The Last Decade

I. Abaitua

20 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Abaitua Spain 12 132 72 69 62 53 21 380
F.S. Mennini Italy 9 62 0.5× 33 0.5× 96 1.4× 40 0.6× 20 0.4× 45 343
Tomasz Kluz Poland 13 75 0.6× 77 1.1× 35 0.5× 112 1.8× 21 0.4× 64 577
John Anderson United States 14 108 0.8× 25 0.3× 120 1.7× 69 1.1× 58 1.1× 52 593
Jessica C. Wilson United States 11 205 1.6× 22 0.3× 41 0.6× 70 1.1× 176 3.3× 11 471
Sohier Yahia Egypt 13 35 0.3× 69 1.0× 50 0.7× 98 1.6× 68 1.3× 49 459
Caterina Mancusi Italy 12 45 0.3× 54 0.8× 66 1.0× 111 1.8× 58 1.1× 22 520
Shoko Arakawa Japan 11 43 0.3× 46 0.6× 68 1.0× 29 0.5× 18 0.3× 19 418
Rasoul Pourebrahim Iran 11 92 0.7× 50 0.7× 20 0.3× 222 3.6× 39 0.7× 33 533
H. C. Van Paassen Netherlands 11 229 1.7× 62 0.9× 38 0.6× 136 2.2× 50 0.9× 12 616
Pei Du China 14 41 0.3× 69 1.0× 82 1.2× 145 2.3× 27 0.5× 37 481

Countries citing papers authored by I. Abaitua

Since Specialization
Citations

This map shows the geographic impact of I. Abaitua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Abaitua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Abaitua more than expected).

Fields of papers citing papers by I. Abaitua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Abaitua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Abaitua. The network helps show where I. Abaitua may publish in the future.

Co-authorship network of co-authors of I. Abaitua

This figure shows the co-authorship network connecting the top 25 collaborators of I. Abaitua. A scholar is included among the top collaborators of I. Abaitua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Abaitua. I. Abaitua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torrent-Farnell, Josep, Marta Comellas, José Luís Poveda, et al.. (2018). The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus. Health Policy. 122(6). 590–598. 2 indexed citations
2.
Paz, Silvia, et al.. (2015). Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain: A Delphi Study. Value in Health. 18(7). A679–A679. 1 indexed citations
3.
Domínguez‐Berjón, M. Felicitas, María D. Esteban‐Vasallo, I. Abaitua, et al.. (2015). Identifying data sources for a national population-based registry: the experience of the Spanish Rare Diseases Registry. Public Health. 129(3). 271–275. 11 indexed citations
4.
Cavero‐Carbonell, Clara, et al.. (2015). Consensus on the criteria needed for creating a rare-disease patient registry. A Delphi study. Journal of Public Health. 38(2). e178–e186. 12 indexed citations
5.
Alonso‐Ferreira, Verónica, et al.. (2014). Childhood vasculitis hospitalizations in Spain, 1997-2011.. PubMed. 65–72. 1 indexed citations
6.
Alonso‐Ferreira, Verónica, I. Abaitua, Óscar Zurriaga, et al.. (2014). National rare diseases registry in Spain: pilot study of the Spanish Rare Diseases Registries Research Network (SpainRDR). Orphanet Journal of Rare Diseases. 9(S1). 5 indexed citations
7.
Alonso‐Ferreira, Verónica, et al.. (2013). Epidemiology of Hereditary Ataxias in Spain: Hospital Discharge Registry and Population-Based Mortality Study. Neuroepidemiology. 41(1). 13–19. 5 indexed citations
8.
Alonso‐Ferreira, Verónica, et al.. (2013). Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries. The European Journal of Health Economics. 15(4). 433–437. 6 indexed citations
9.
Hernández‐Martín, Á., et al.. (2013). Reference centers for epidermolysis bullosa and ichthyosis: an urgent need in spain. Actas Dermo-Sifiliográficas. 104(5). 363–366. 2 indexed citations
10.
Hernández‐Martín, Á., et al.. (2013). Unidades de referencia para epidermólisis ampollosas e ictiosis: una necesidad urgente en España. Actas Dermo-Sifiliográficas. 104(5). 363–366. 4 indexed citations
11.
Alonso‐Ferreira, Verónica, et al.. (2011). Cost‐effectiveness analysis of burning mouth syndrome therapy. Community Dentistry And Oral Epidemiology. 40(2). 185–192. 15 indexed citations
12.
Alonso‐Ferreira, Verónica, et al.. (2011). Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990–2005). Amyotrophic Lateral Sclerosis. 12(3). 192–198. 16 indexed citations
13.
Alonso‐Ferreira, Verónica, et al.. (2011). Public health research on rare diseases.. PubMed. 11–6. 11 indexed citations
14.
Paz, Manuel Posada de la, et al.. (2008). Enfermedades raras: Concepto, epidemiología y situación actual en España. Anales del Sistema Sanitario de Navarra. 31. 9–20. 24 indexed citations
16.
Gelpı́, Emilio, Manuel Posada de la Paz, Benedetto Terracini, et al.. (2002). The Spanish Toxic Oil Syndrome 20 Years after Its Onset: A Multidisciplinary Review of Scientific Knowledge. Environmental Health Perspectives. 110(5). 457–464. 42 indexed citations
17.
Gelpı́, Emilio, Manuel Posada de la Paz, Benedetto Terracini, et al.. (2002). The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge.. Environmental Health Perspectives. 110(5). 457–464. 65 indexed citations
18.
Paz, Manuel Posada de la, Rossanne M. Philen, Robert H. Hill, et al.. (1999). Epidemiologic Evidence for a New Class of Compounds Associated with Toxic Oil Syndrome. Epidemiology. 10(2). 130–134. 73 indexed citations
19.
Gallardo, Soledad, Victoria del Pozo, Blanca Cárdaba, et al.. (1994). Immunological basis of toxic oil syndrome (TOS). Toxicology. 93(2-3). 289–299. 25 indexed citations
20.
Paz, Manuel Posada de la, et al.. (1987). Toxic-oil syndrome: Case reports associated with the ITH oil refinery in Sevilla. Food and Chemical Toxicology. 25(1). 87–90. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026